Liber Pharmaceuticals’ statement on ingredient safety and device design of its Nicovape Q products
Pharmacy Practice Notice Published on 10 March 2026 Liber Pharmaceuticals’ statement on ingredient...
Pharmacy Practice Notice Published on 10 March 2026 Liber Pharmaceuticals’ statement on ingredient...
Pharmacy Practice Notice Published on 9 January 2025 Transition to Nicovape® Q2 System...
Pharmacy Practice Notice Published on 22 November 2024 Scheduling of NVPs in Western...